Loading clinical trials...
Loading clinical trials...
This multicenter, real-world study introduces a novel Hematoxylin-eosin staining(H\&E)-based four tumor microenvironment (TME) system (HEFTME system) assisting in prognostic prediction and precise adj...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University First Hospital
Collaborators
NCT07321210 · Upper Tract Urothelial Carcinoma, Lymph Node Dissection
NCT06948552 · Upper Tract Urothelial Carcinoma
NCT06040762 · Bladder Cancer, Urothelial Carcinoma, and more
NCT06668493 · Low-grade Upper Tract Urothelial Carcinoma
NCT07225374 · Upper Tract Urothelial Carcinoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions